12 Health Care Stocks Moving In Monday's Pre-Market Session

Loading...
Loading...

Gainers

  • Cyclerion Therapeutics CYCN stock rose 33.6% to $0.58 during Monday's pre-market session. The company's market cap stands at $25.3 million. The company's, Q4 earnings came out 3 days ago.
  • Adial Pharmaceuticals ADIL stock moved upwards by 21.8% to $0.43. The company's market cap stands at $12.2 million.
  • Healthcare Triangle HCTI shares moved upwards by 17.34% to $0.49. The company's market cap stands at $20.2 million.
  • Pyxis Oncology PYXS stock moved upwards by 15.83% to $2.56. The company's market cap stands at $94.6 million. As per the news, the Q4 earnings report came out 3 days ago.
  • Coeptis Therapeutics COEP shares increased by 14.86% to $1.7. The market value of their outstanding shares is at $8.6 million.
  • Lantern Pharma LTRN stock moved upwards by 14.06% to $5.15. The market value of their outstanding shares is at $55.9 million.

Losers

  • Unity Biotechnology UBX stock fell 45.8% to $2.25 during Monday's pre-market session. The market value of their outstanding shares is at $32.2 million.
  • NuCana NCNA stock decreased by 31.46% to $0.85. The company's market cap stands at $44.3 million.
  • Nymox Pharmaceutical NYMX shares declined by 20.25% to $0.32. The market value of their outstanding shares is at $28.6 million.
  • Pharming PHAR stock fell 17.05% to $12.41. The company's market cap stands at $809.6 million.
  • Sonnet BioTherapeutics SONN stock declined by 10.66% to $0.55. The market value of their outstanding shares is at $11.0 million.
  • Pear Therapeutics PEAR stock decreased by 10.12% to $0.26. The company's market cap stands at $36.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...